Related Experiment Video
Updated: Aug 14, 2026
Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Published on: November 21, 2011
On the Edge of Benefit and Harm: Reactive Oxygen Species in Cancer
1Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino 142290, Russia.
Abstract:
Reactive oxygen species (ROS) are central regulators of cancer biology and represent a double-edged target in oncology. At physiological levels, ROS support signal transduction, proliferation, differentiation, and immune responses, whereas sustained ROS imbalance promotes DNA damage, genomic instability, metabolic reprogramming, and remodeling of the tumor microenvironment, thereby contributing to tumor initiation, progression, metastasis, and therapy resistance. Conversely, because many cancer cells operate close to the limit of tolerable oxidative stress, further ROS elevation can trigger apoptosis, ferroptosis, immunogenic cell death, and other cytotoxic programs. This review summarizes the major intracellular and microenvironmental sources of ROS, the mechanisms by which redox signaling shapes malignant transformation and tumor adaptation, and the antioxidant systems that buffer oxidative stress in cancer cells. We further discuss current therapeutic approaches based on both ROS suppression and ROS amplification, including redox-modulating small molecules, radiotherapy, photodynamic and sonodynamic therapy, catalytic nanomaterials, and ROS-responsive prodrugs and drug delivery systems. Particular attention is given to the context-dependent effects of ROS, the antioxidant paradox, tumor heterogeneity, hypoxia, off-target toxicity, and the need for robust redox biomarkers. A deeper understanding of tumor-specific redox vulnerabilities will be essential for developing precise and clinically effective ROS-oriented cancer therapies.
Insights
Reactive oxygen species (ROS) are crucial in cancer, acting as both promoters and potential targets. Manipulating ROS levels offers novel therapeutic strategies for cancer treatment by exploiting tumor-specific vulnerabilities.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
- Cancer Therapeutics
Background:
- Reactive oxygen species (ROS) play a dual role in cancer, regulating normal cellular functions at physiological levels.
- Sustained ROS imbalance contributes to cancer hallmarks like genomic instability, metabolic reprogramming, and tumor microenvironment modulation.
- Cancer cells often exist near their oxidative stress limit, making them susceptible to further ROS elevation.
Purpose of the Study:
- To review the sources and signaling mechanisms of ROS in cancer biology.
- To explore the dual role of ROS in tumor initiation, progression, metastasis, and therapy resistance.
- To discuss current and emerging therapeutic strategies targeting ROS in cancer.
Main Methods:
- Comprehensive literature review of intracellular and microenvironmental ROS sources.
- Analysis of redox signaling pathways in malignant transformation and tumor adaptation.
- Evaluation of antioxidant systems within cancer cells.
- Synthesis of data on ROS-modulating therapies, including small molecules, radiation, and novel drug delivery systems.
Main Results:
- ROS are integral to cancer cell signaling, adaptation, and resistance mechanisms.
- Both ROS suppression and amplification strategies show therapeutic potential.
- Context-dependent ROS effects, tumor heterogeneity, and hypoxia complicate therapeutic targeting.
Conclusions:
- Understanding tumor-specific redox vulnerabilities is key to developing effective cancer therapies.
- Targeting ROS offers a promising avenue for precise and clinically impactful oncology treatments.
- Further research into redox biomarkers and minimizing off-target toxicity is essential.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:25Bioactivation and Tissue Toxicity
01:25Mutagenicity and Carcinogenicity